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Paediatric cerebral venous sinus thrombosis (CVST) is a rare complication associated 
with many underlying illnesses. It often results in severe neurological complications, 
which can be severely debilitating. 
The aim is to describe the clinical presentation of paediatric patients diagnosed with 
CVST who presented to Tygerberg Children’s Hospital (TCH). 
Materials and methods: 
This is a retrospective, descriptive case series looking at patients younger than 14 
years of age residing in the Western Cape who were referred to TCH and diagnosed 
with CVST based on neuroimaging over a six-year period. 
Results: 
Thirty-five patients were included in this study with a male predominance of 57% and 
a mean age at presentation of 17 months with the majority of patients (80%) 
presenting during the first year of life. The mean weight-for-age was on the -2 Z-
score. Acute gastro-enteritis (AGE) was the most common underlying clinical 
condition associated with the development of CVST. All of the patients with AGE 
were hypernatraemic. The majority of our patients (62.9%) had multiple sinus 
involvement; the transverse sinus was the most common sinus involved. Mortality 
was 5.7% and morbidity 37.1%. Poor outcome was not associated with convulsions or 
with decreased level of consciousness at presentation. 
Conclusion: 
Our study is the first of its kind in South Africa. We demonstrated that 
hypernatraemia and AGE appear to be significant acute underlying triggers for 
developing CVST. In this study CVST is more common in younger patients, severe 
underweight for age and associated with AGE than has previously been reported in 
studies from high income countries. 




Pediatriese serebrale veneuse sinus trombose (SVST) is ‘n raar komplikasie wat kan 
volg op verskeie onderliggende mediese toestande. Dit kan moontlike debiliterende 
neurologiese komplikasies tot gevolg hê. 
Die doel van hierdie studie is om die kliniese beeld van pasiente te beskryf wat met 
SVST in Tygerberg Kinderhospitaal presenteer. 
Materiale en metodes: 
Hierdie is n retrospektiewe, deskriptiewe gevalle reeks van kinders onder 14 jaar wat 
met SVST gediagnoseer is in ‘n 6 jaar periode in Tygerberg Kinderhospitaal in die 
Wes-Kaap. 
Bevindinge: 
Vyf-en-dertig pasiënte was in die reeks ingesluit met ‘n manlike predominansie van 
57%. Die gemiddelde ouderdom van die kinders was 17 maande en 80% van die 
kinders was jonger as 1 jaar oud. Die gemiddelde gewig-vir-ouderdom was op die -2 
Z-telling. Die algemeenste onderliggende siekte-toestand wat met die ontwikkeling 
van SVST geassosieër was, was akute gastro-enteritis (AGE). Al die pasiënte met 
AGE het geassosieerde serum hipernatremie gehad. Die transverse sinus was die sinus 
wat die meeste geaffekteer was en in die meerderheid van die pasiënte (62.9%) was 
meer as 1 sinus aangetas. Morbiditeit was 37.1% met ‘n mortaliteit van 5.7%. 
Konvulsies en ‘n onderdrukte bewussyn met presentasie was nie geassosieer met ‘n 
slegte uitkoms nie. 
Konklusie: 
Hierdie studie is die eerste van sy soort in Suid-Afrika. Ons het gewys dat AGE en 
hipernatremie belangrike onderliggende toestande is in die ontwikkeling van SVST. 
In hierdie studie is SVST meer algemeen in jonger kinders, dié wat ondergewig vir 
ouderdom is en die wat geassosieer is met AGE as wat voorheen gepubliseer is in 
hoër inkomste lande.    
Stellenbosch University  https://scholar.sun.ac.za
6 
Table of contents 
Chapter 1: Introduction pg. 7 
Chapter 2: Literature review pg. 8 
Chapter 3: Research justification pg. 13 
Chapter 4: Aims and objectives pg. 14 
Chapter 5: Materials and methods pg. 15 
Chapter 6: Data management pg. 17 
Chapter 7: Statistical analysis  pg. 20 
Chapter 8: Ethical considerations pg. 21 
Chapter 9: Results pg. 22 
Chapter 10: Discussion pg. 31 
Chapter 11: Recommendations pg. 36 
References pg. 37 
Appendix A: Protocol  pg. 40 
Appendix B: Data capture sheet pg. 55 
Appendix C: Confirmation of Ethical approval pg. 57 
Stellenbosch University  https://scholar.sun.ac.za
 7 
A Retrospective Review of Paediatric Cerebral Venous Sinus Thrombosis in a 






Paediatric cerebral venous sinus thrombosis (CVST) is a rare complication that occurs 
in children following several precipitating factors. CVST results in severe 
neurological complications, which are often severely debilitating. Although this 
complication has been reported amongst children living in high-income countries 
there is very little data on the prevalence, causes and outcome of children that develop 
CVST in resource-constrained countries, especially sub-Saharan Africa. The aim of 
this thesis is to review the literature and report on CVST in a population of children 
living in a middle-income African country.   






Paediatric cerebral venous sinus thrombosis (CVST) is a rare disorder with an 
estimated incidence of between 0.4 - 0.67 per 100,000 children in developed 
countries.(1) The severe neurological sequelae and high mortality of this devastating 
disease emphasize the need for high-quality studies within this field. No data on 
paediatric CVST are known for South Africa or even continental Africa. Most data 




As many as 43% of CVST cases occur in the first month of life (1), with an incidence 
of 2.6 per 100,000 neonates per year reported in a series investigating a neonatal 
population.(2) After the neonatal period CVST is almost equally distributed amongst 
the sexes with a mean age at presentation of 4 - 6 years.(1–7) The incidence of CVST 
is probably underestimated for several reasons in children with CSVT, particularly 
neonates. Children often present with subtle neurologic signs making it a challenging 
diagnosis and the clinical picture overlaps with other causes of neurological disease. 
The under diagnosis of CVST is further complicated by older neuro-imaging 
techniques, the variable anatomy of the cerebral sino-venous system and rapid 




The venous sinus is a cavity formed between the endosteal and meningeal layers of 
the dura. Channels that allow venous blood to drain from the cranium into the sinuses 
connect the sinuses. CVST refers to the complete or partial occlusion of the main 
sinuses. Thrombosis within the sinus system results in outflow obstruction of the 
venous system resulting in venous congestion and consequently an increase in 
capillary hydrostatic pressure, driving fluid into the interstitium and producing 
cerebral oedema. This cerebral oedema increases intracranial pressure, which further 
impairs the venous drainage. These factors result in intracranial hypertension and/or 
Stellenbosch University  https://scholar.sun.ac.za
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venous infarcts. Formation of thrombi in venous channels draining the brain is a 
consequence of the characteristic risk factors described by Virchow’s triad, which 
includes vessel wall trauma, stasis and a hypercoagulable state. 
 
Aetiology 
The origin and pathophysiology of CVST is poorly understood. Published data 
suggest that CVST is multifactorial in origin with many associated underlying 
illnesses or chronic conditions.(1,2,4–7,9–11) Aetiological factors can be grouped in 
three categories: Chronic underlying illnesses, acute associated conditions and pro-
thrombotic states. Patients who are diagnosed with CVST seem to have had one or a 
combination of these risk factors. 
 
Associated acute conditions include common childhood systemic illnesses including 
infections, dehydration, fever and anaemia.  Associated chronic conditions include 
malignancies, nephrotic syndrome, systemic lupus erythematosis and congenital 
cardiac diseases.  
 
Infection appears to be a significant trigger in previously well children without an 
underlying medical condition. Infections associated with CVST can either be 
systemic, such as bacterial sepsis, or regional, such as meningitis, mastoiditis and/or 
otitis media. Other local head and neck disorders can cause thrombosis due to local 
venous stasis. These include recent head/neck surgery, head trauma and CNS 
tumours.  
 
CVST has been described as a complication of L-asparaginase use in the treatment of 
acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma. L-asparaginase is 
postulated to create a pro-thrombotic state, alone or in combination with other 
chemotherapeutic agents.(4,6,12,13) 
 
Anaemia is frequently observed in children with CVST(5,7), though mechanisms for 
anaemia to contribute to thrombus development are incompletely understood. Iron-
deficiency microcytic anaemia appears to be the most common cause of anaemia 
associated with CVST. Previously healthy children with a stroke were 10 times more 
likely to have iron-deficiency anaemia than healthy children without stroke.(14) 
Stellenbosch University  https://scholar.sun.ac.za
 10 
 
Prothrombotic states may cause or contribute to the development of CVST in 
children. Prothrombotic states have been identified in 24- 64% of children with 
CVST.(1,2,5) The association between prothrombotic risk factors and CVST proves 
only to be statistically significant if the thrombosis is associated with an underlying 
medical condition. (2,11) The cause of the hypercoagulable state is difficult to 
determine as prothombotic tests are complex and are difficult to interpret as the 
number and types of tests done over the past 3 decades have varied.   
 
CVST has been described as a complication of dehydration in children. Although 
CVST secondary to hypernatraemic dehydration in breastfed neonates has been 
described in the literature (15,16), there is limited clinical data on CSVT secondary to 
hypernatraemic dehydration in the setting of diarrhoeal disease in infants and young 
children. However, CVST is accepted as a complication of hypernatraemic 
dehydration due to diarrhoeal diseases by paediatric gastroenterologists and 
neurologists. (Personal communication: Nel ED, Solomons R) 
 
A review article by Roach et al. stated that hypernatraemia in conjunction with 
dehydration may cause CVST. (17) He based his observation on two studies 
published in the 1950’s and 1960’s by Finberg and Macauly, however this association 
has been infrequently reported in the literature. 
 
Clinical Presentation 
The clinical manifestations of CVST can be subtle and non-specific. Due to its rarity 
and the non-specific clinical features at presentation, the diagnosis of CVST is often 
delayed or may be missed altogether. One study reported an average delay in 
diagnosis of CVST of up to 4 days(6). Most common clinical features at presentation 
are seizures, fever, drowsiness/stupor, headaches and generalized weakness. Common 
neurological abnormalities at presentation are decreased level of consciousness, 
cranial nerve palsies and hemiparesis. While most of the clinical symptoms can occur 
at any age, seizures are more common in neonates, whereas focal and diffuse 
neurologic signs are more common in older infants and children.(1,2,5–7,9,10) 
 
Topographic location of thrombi 
Stellenbosch University  https://scholar.sun.ac.za
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The superficial venous system (dural venous sinuses) is more frequently involved 
than the deep system (composed of traditional veins inside the deep structures of the 
brain, which join behind the midbrain to form the vein of Galen). The most common 
sites of CVST are the transverse, superior sagittal, sigmoid, and straight sinuses.(6) 
The topographic locations involved differ depending on the nature of the underlying 
intracranial pathology. In one study the transverse sinus was mostly affected 
following acute bacterial mastoiditis,(18) while in a separate study, lateral sinus 
thrombosis was associated with mastoiditis and otitis media.(19) 
 
Treatment 
The treatment of CVST in children is not well described. The initial management is to 
treat the underlying cause or associated clinical condition and administer general 
supportive care. The only randomized placebo-controlled trial of intravenous heparin 
in adults was stopped early because there was clear evidence of benefit, particularly in 
terms of mortality. A randomised placebo-controlled trial of subcutaneous low 
molecular weight heparin (LMWH) in adults showed a trend for better outcome in the 
treated group.  
 
Anticoagulation therapy has been used inconsistently in children with CVST. The use 
has been controversial as previously anticoagulation was associated with intracranial 
haemorrhage. More recently case series have shown that LMWH can be used safely in 
children, however outcome data is limited to support the efficacy of this treatment.(5) 
DeVeber(1) initiated a prospective cohort study of anticoagulant therapy in 30 
children with CVST from 1992 to 1996, and reported a mortality rate of 3 out of 8 
untreated children, compared with 0 of 22 treated children. One series suggested that 
cognitive outcome may be better in the anticoagulated group.(5) This highlights the 
importance of further studies investigating treatment options in paediatric patients 
with CVST. 
 
Recent Canadian guidelines for the treatment of CVST states that children with no 
associated intra-cranial haemorrhage should be anticoagulated with LMWH or 
unfractionated heparin (UFH). In the presence of haemorrhage resulting in a local 
mass effect or intraventricular haemorrhage, it is reasonable to withhold 
anticoagulation. The presence of less significant intracranial haemorrhage or 
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parenchymal infarctions are not contraindications to anticoagulation.  
 
The use of anticoagulant agents to prevent CVST has a large evidence base in the 
adult population, but is very limited in children. There is no evidence for the use of 
aspirin for CVST prophylaxis in a paediatric population.(20) 
 
Prognosis and outcome 
CVST has poor prognosis with morbidity that varies from 17%-62% and mortality 
between 10%-12%.(1,4–7,9) In an American study, they found that permanent 
neurological disability was associated with thrombosis of the deep veins with 
associated infarctions.(3) Coma is the only predictor of death in childhood 
CVST.(5)One study reports that older age and involvement of the lateral and/or 
sigmoid sinuses are associated with good cognitive outcome.(5) Common long-term 
sequelae include motor impairment, cognitive impairment, developmental and/or 
speech delay, and visual impairment.(1,21,22) 
 
Recurrence of CVST is uncommon. The Canadian study by DeVeber et al in 160 
children with CVST identified 12 (<1%) children with recurrent thrombosis.(1) This 
was supported by an additional study in 266 children with CVST with recurrence of 
venous thrombosis in 3%.(11)  





Previous studies on cerebral venous sinus thrombosis were performed in developed 
countries of Europe, North America and Australasia. No study on CVST has been 
performed in Sub-Saharan Africa. The aetiological differences of CSVT between 
developed and resource-constrained countries such as South Africa are not known. It 
is hypothesized that the aetiology will lean towards CVST being associated with 
common infectious diseases, such as diarrhoea and meningitis, as these diseases 
commonly occur in Southern Africa. Although dehydration is mentioned as a cause of 
CVST in developed countries, the cause of the dehydration and serum osmolality 
derangements associated with dehydration has not been reported. 
 
Clinicians practicing in low and middle-income countries widely accept that CVST is 
a complication of hypernatraemic dehydration caused by diarrhoeal diseases but there 
is a paucity of reports investigating this association.  
 
Secondly, the treatment of paediatric CVST remains controversial. There are 
currently no well-designed clinical trials in children to support acute or chronic anti-
thrombotic therapy with anticoagulants or antiplatelet agents once the diagnosis of 
CVST is made. Randomized control trials in the paediatric population are required in 
order for treatment consensus to be reached. 
 
The purpose of this study was to describe the confirmed paediatric cases of CVST in a 
South African population admitted to a tertiary care hospital and report the potential 
precipitating factors, clinical presentation, thrombus location and short-term 
neurological outcome. This will serve as an important pilot study of paediatric 
cerebral venous sinus thrombosis in Southern Africa. It is hoped that results from this 
study will lead to improved awareness of the CVST in neonates and children, improve 
the understanding of the associated risk factors and direct optimal therapy to decrease 
the mortality and morbidity.   
Stellenbosch University  https://scholar.sun.ac.za
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Chapter 4 
Aim and objectives 
 
Aims of the study 
 
To describe the clinical picture of paediatric patients diagnosed with CVST who 
presented to Tygerberg Children’s Hospital and investigate the patient profile, 




To describe patients who presented to Tygerberg Children’s Hospital diagnosed with 
CVST with regards to the following: 
 
 Age at presentation. 
 The signs and symptoms on admission and any neurologic deficit noted at 
presentation. 
 Any associated acute medical illnesses or underlying chronic medical conditions. 
 To assess delay (in days) from presentation to diagnosis.  
 Document the thrombotic location on CT scan. 




 To document electrolyte abnormalities at presentation.  
 To document haematological abnormalities at presentation.  
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Chapter 5 








Tygerberg Children’s Hospital (TCH) in Cape Town is a large tertiary center that 
accepts referrals from clinics, day hospitals, and district hospitals as well as regional 
hospitals from within the Western Cape Province of South Africa. Tygerberg 
Children’s Hospital services a population of approximately 2,5 million people and 




Children younger than 14 years of age (including neonates) admitted to the TCH 





Children younger than 14 years of age (including neonates) admitted to Tygerberg 
Children’s Hospital paediatric wards from January 2009 to December 2014 who were 




 Confirmed Diagnosis of CVST based on neuroimaging (Brain computed 
tomography (CT scan) imaging) 
 Admission to TCH between 1 January 2009 and 31 December 2014 
 Age between 1 day and 14 completed years 
 




 Incomplete patient documentation 





Study patients were identified from discharge summaries obtained from the different 
paediatric wards in TCH. Patients who were diagnosed as suffering from CVST were 
crosschecked against the neuro-radiology database, and only those children and 
neonates with a confirmed neuro-radiological diagnosis of CVST were included.   







 The patient’s clinical data was collected retrospectively from their clinical 
patient file, either from the hard copy patient files or from the electronic 
patient files on the Enterprise Content Management (ECM) system. The ECM 
system did not contain all patient files due to its recent inception in Tygerberg 
Hospital. 
 Patient radiological data, MRI and CT Scan images, was collected from 
Tygerberg Hospital’s iSite enterprise.  
 Patient blood results were collected from the National Health Laboratory 
Service electronic database. Laboratory parameters that were investigated 
included serum sodium, urea, creatinine, haemoglobin and the mean 
corpuscular volume levels. The normal values as used by the clinical service 
were used.  
 After data capturing was completed, the data was categorized, processed and 
analyzed. 
 All data was stored in Microsoft Excel on a password-protected computer. 




The following data was captured on a data capture sheet for each individual patient: 
 
 Demographic information:   
- Age and weight on admission.  
- Gender 
- The weight on presentation for each patient was standardized on the 
weight-for-age Z score chart. 
 
 Associated underlying illnesses:  
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- These were conditions diagnosed alongside the CVST during the same 
admission. 
- If an infective illness was identified: Micro-organism microscopy and 
culture was performed. 
 
 Chronic illnesses:  
- These are underlying chronic medical conditions that the patient was 
known with. 
 
 Signs and symptoms at presentation:  
- These were the presenting signs and symptoms in the paediatric 
emergency ward. 
 
 Neurological signs at presentation:  
- Neurological fallout present at presentation to the paediatric emergency 
ward, including: 
1. Loss of consciousness (Glasgow Coma Scale) 
2. Focal motor deficit 
 
 Seizures:   
- Seizures present at the time of diagnosis of CVST.  
- Character of seizure – generalized or focal.   
 
 Time delay of diagnosis (Time from admission to imaging).  
 
 Serum electrolyte abnormalities: 
- Serum sodium on admission (within 24 hours). 
- Serum urea and creatinine on admission (within 24 hours). 
 
 Haemoglobin and mean corpuscular volume level at diagnosis. 
 
 Neurological deficit on discharge from Tygerberg Children’s Hospital 
 
 Neuro Imaging: 
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- The diagnosis of CVST was confirmed by independent review by two 
radiologists. Disagreement in interpretation was resolved by consensus. 
- Radiological data that was captured: 
1. Imaging technique used 
2. Location of thrombosis 
3. Size of thrombosis 
4. Presence of associated venous infarct or bleed 




 Cerebral venous sinus thrombosis:  The presence of acute blood clot formation in 
the dural venous sinuses, diagnosed by neuro-imaging. 
 
 Hypernatraemia: Serum sodium level >145mmol/L 
 
 Anaemia: A haemoglobin level of less than 14g/dL in the first month of life, less 
than 10g/dl between 1 and 12 months and <11g/dl in older children, were 
regarded as anaemic.(23)   





Statistica® version 12 (Statsoft) was used to analyse the data. 
 
Descriptive Statistics: 
Variables recorded during the study was summarized using standard descriptive 
statistical methods: 
 
 Continuous variables that follow a normal distribution were described by a mean 
and standard deviation. 
 Continuous variables that do not follow a normal distribution were described by 
the median and inter-quartile range. 




 Differences between groups (e.g. presence or absence of neurological 
complications, venous infarct, associated diseases) were analyzed by analysis of 
variance (ANOVA) or the non-parametric equivalent (where data could be 
categorised). 
 Associations between variables were analyzed by regression (linear, logistical, 
simple or multiple) analysis. (e.g. association between highest serum sodium 
concentration and presence of neurological outcome)  







Patient demographic data was kept strictly confidential at all times by only using 
study numbers in the data management and analysis stages of this study. The 
information for this study was collected in such a way as to protect patient 
confidentiality at all times. The data capture sheet and electronic database only 
contained a study code. The identifying information that is linked to the study code 
was kept in a separate, password-protected database. Access to this database was 
restricted to the primary investigator. All data will be kept for a maximum of 5 years 





A waiver of individual informed consent was granted by the Human Research Ethics 
Committee, as this was a retrospective study with minimal risks to the study 
participants. Permission was requested and granted to conduct this retrospective study 




The Committee of Human Research of the Faculty of Health Sciences, University of 
Stellenbosch, approved the protocol for the proposed study. Ethical approval 
(S14/09/194) was obtained before data collection was started. (Appendix C)  





Fifty-seven patients were identified with CVST from their electronic discharge 
summaries. Ten patients were excluded from the study, as their neuroimaging was 
unavailable. A further 12 were excluded after their neuroimaging was found to be not 





Twenty (57%) of the patients who presented with CVST were males and 15 (43%) 
were female.  The mean age of the study patients at presentation was 17 months 
(range 2 weeks to 12 yrs).  Five patients (14.3%) presented in the first month of life; 
23 patients (65.7%) presented between the 1st and the 12th month of life; 3 patients 
(8.6%) were between 1 to 5 years old while 4 patients (11,4%) were older than 5 
years. The mean weight-for-age of our patients was exactly -2.0 Z score (SD 2.03). 
 
Symptoms and signs on presentation: 
 
Symptoms on presentation were non-specific in nature. Twenty-two patients (62.8%) 
presented with vomiting, 23 (65.7%) presented with diarrhoea, 12 (34,3%) presented 
with fever, 10 (28.6%) presented with poor feeding and 3 (8.6%) presented with 
shortness of breath. Convulsions were present in 71.4% (25 patients) of which 17 
(68%) presented with generalized and 8 presented with focal convulsions. On 
assessment, 77.1% (27 patients) had a normal level of consciousness on presentation, 
while 8 (22.9%) had a decreased level of consciousness. (see Table 1) 
  
Eleven patients (31.4%) had neurological fallout on presentation. One patient had a 
hemiparesis, 2 patients had increased tone in their upper limbs, 1 patient had an 
opsithotonic posture and 1 patient had a decorticate posture. Six patients had globally 
increased tone on presentation. 
 




Signs and symptoms Number (n=35) Percentage (%) 
Fever 12 34.3% 
Vomiting 22 62.8% 
Diarrhoea 23 65.7% 
Poor feeding 10 28.6% 










Depressed LOC 27 77.1% 
Neurological deficit 11 31.4% 
Signs and symptoms on presentation of patients diagnosed with CVST 




The following chronic medical conditions were present: 4 patients (11.4%) were born 
prematurely and 5 (14.3%) were HIV positive. The blood CD4 counts and viral load 
counts were not ascertained. One patient (2.9%) had Tolosa-Hunt syndrome, 1 patient 
had a cow’s milk protein allergy and 1 patient had asthma. (see Table 2) 
 
The following acute medical conditions were present on admission. Twenty-four 
patients (68.6%) had associated acute gastro-enteritis, 9 patients (25.7%) had 
associated meningitis, 6 patients (17.1%) had pneumonia, 6 patients had associated 
sepsis, 4 patients (11.4%) had a brain abscess, 2 patients had protein-energy-
malnutrition in the form of kwashiorkor, 2 patients (5.7%) had a urinary tract 
infection, 2 patients had presumed (unproven but suspected) disseminated 
tuberculosis, 2 patients had chronic suppurative otitis media and 1 patient (2.9%) had 
encephalitis. Two patients (5.7%) had no associated acute conditions. None of these 
patients had a prothrombotic screen. 
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Eight patients (22.9%) had 3 or more acute associated conditions, 11 patients (31.4%) 




Acute associated conditions Number (n=35) Percentage (%) 
Gastro-enteritis 24 68.6% 
Meningitis 9 25.7% 
Pneumonia 6 17.1% 
Septicaemia 6 17.1% 
Kwashiorkor 2 5.7% 
UTI 2 5.7% 
Disseminated TB 2 5.7% 
CSOM 2 5.7% 
Brain abscess 4 11.4% 
Encephalitis 1 2.9% 
Mastoiditis 1 2.9% 
   
Chronic underlying conditions   
Prematurity 4 11.4% 
HIV 5 14.3% 
Asthma 1 2.9% 
Tolosa-Hunt syndrome 1 2.9% 
Cow’s milk protein allergy 1 2.9% 
   
Number of associations   
≥3 associations 8 22.9% 
2 associated conditions 11 31.4% 
1 associated condition 14 40% 
0 associated conditions 2 5.7% 
Acute and chronic underlying conditions associated with CVST. 
UTI: urinary tract infection; TB: tuberculosis; CSOM: chronic suppurative otitis 
media; HIV: human immunodeficiency virus  




Delay in diagnosis: 
 
The time from initial presentation to Tygerberg Children’s Hospital to the time of 





All 35 patients had contrasted CT scan neuroimaging to confirm the diagnosis. 
Thirty-four patients (97.1%) had superficial cerebral sinus involvement and 10 
(28.6%) had deep cerebral sinus involvement. Twenty-five patients (71.4%) had 
superficial involvement alone, 1 patient (2.9%) had deep involvement alone and 9 
patients (25.7%) had combined superficial and deep venous sinus involvement. 
Thirteen patients (37.1%) had a single sinus involved and 22 patients (62.9%) had 
multiple sinus involvement.  
 
A total number of 109 sinuses were involved in our series of 35 patients. The most 
frequent sinus involved was the left transverse sinus. Nineteen patients (54.3%) had 
left transverse sinus involvement followed by 14 patients (40.0%) with superior 
sagittal sinus involvement, 13 patients (37.1%) with right transverse sinus 
involvement and 12 patients (34.3%) with straight sinus involvement. Of the 13 
patients with a single sinus involvement, 6 patients had superior sagittal sinus 
involvement which was the most frequent single sinus involved, followed by the 
straight sinus (3), left transverse sinus (2), right transverse sinus (1) and right sigmoid 
sinus (1). 
 
Associated brain parenchymal involvement was assessed. Four patients (11.4%) had 
radiological features of haemorrhage, 3 patients (8.6%) had hydrocephalus and 20 








Venous system involved  Number (n=35) Percentage (%) 
Superficial system -total 34 97.1% 
Deep system - total 10 28.6% 
   
Superficial system - alone 25 71.4% 
Deep system – alone 1 2.9% 
Combined 9 25.7% 
   
Single sinus involvement 13 37.1% 
Multiple sinus involvement 22 62.9% 
   
Brain parenchymal involvement   
Parenchymal oedema 20 57.1% 
Haemorrhage 4 11.4% 
Hydrocephalus 3 8.6% 
Radiological features: Breakdown of the involvement of the superficial and deep 





Sinus Thrombosed Number (n=109) % of  total sinuses % of total 
patients 
Superficial system 
SSS 14 12.8% 40.0% 
ISS 4 3.7% 11.4% 
Left transverse sinus 19 17.4% 54.5% 
Right transverse sinus 13 11.9% 37.1% 
Left sigmoid sinus 2 1.8% 5.7% 
Right sigmoid sinus 1 0.9% 2.9% 
Straight sinus 12 11.0% 34.3% 
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Cortical veins 6 5.5% 17.1% 
Deep system    
Right ICV 9 8.3% 25.7% 
Left ICV 9 8.3% 25.7 
Vein of Galen 7 6.4% 20.0% 
Right BVR 4 3.7% 11.4% 
Left BVR 3 2.8% 8.6% 
Right TSV 3 2.8% 8.6% 
Left TSV 3 2.8% 8.6% 
Radiological features: Breakdown of specific sinus involvement. 
SSS: superior sagittal sinus; ISS: inferior sagittal sinus; ICV: internal cerebral vein; 





The average serum sodium level of the patients on presentation was 152.1mmol/L. 
Seventeen patients (48,6%) were hypernatraemic. Fifteen patients (42.9%) had 
normal sodium levels (135-145mmol/L), 2 patients (5.7%) had a sodium level below 
135mmol/L and in 1 patient the serum sodium was not available. The highest 
recorded serum sodium was 199mmol/L. Of the 24 patients who had associated acute 
gastro-enteritis, 17 (70.8%) had hypernatraemia. All cases of serum hypernatraemia 
were associated with acute gastro-enteritis. Patients with hypernatraemia were more 
likely to have thrombosis of the deep venous sinus system (p< 0.006) and an age of 
less than 6 months (p<0.05) 
  
Renal function in our patients was difficult to assess without information about urine 
output and glomerular filtration rate, but the average creatinine level of our patients 
was 79.8umol/l and 18 patients (51.4%) had an urea:creatinine ratio >10 that might 
indicate acute kidney injury with intravascular volume depletion. 
 
At presentation the mean haemoglobin level of our patients on presentation was 
9.7g/dL  2.4 g/dL. Twenty-five patients (71.4%) were anaemic when corrected for 
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age. Four out of the 5 patients who presented in the first month of life were anaemic 
while 17 (74%) infants between 1-12 months and 4 (57%) children older than 1year 
were anaemic. The average mean corpuscular volume of our patients was 87.7fL  
12.4fL. Five patients (14.3%) had a microcytic anaemia on presentation. 
 
Of the 35 patients in our study, 11 (31.4%) had organisms isolated in various 
specimen samples. Seven patients (20.0%) had positive blood cultures of which 3 
were positive for Group B Streptococcus (all 3 patients were neonates between 2 and 
3 weeks old), 2 were positive for Coagulase negative Staphylococcus, 1 was positive 
for both Enterococcus faecalis and Morganella moranii and 1 was positive for 
Candida albicans. 
 
Two patients (5.7%) had positive isolates in their stool, 1 patient had a positive 
Rotavirus PCR and 1 patient had a positive stool culture for Campylobacter jejuni. 




Laboratory findings Number (n=35) Percentage (%) 
Serum Sodium (mmol/l)   
- >145 17 48.6% 
- 135-145 15 42.9% 
- <135 2 5.8% 
- unknown 1 2.9% 
Haemoglobin (g/dL)   
-Age <1 month, Hb <14 4 11.4% 
-Age 1-12 months, Hb<10 17 48.6% 
-Age >12 months, Hb<11 4 11.4% 
Organisms isolated   
Blood 7 20% 
-GBS 3 8.6% 
-CNSA 2 5.8% 
-Enterococcus faecalis 1 2.9% 
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-Morganella morganii 1 2.9% 
-Candida albicans 1 2.9% 
Stool 2 5.8% 
-Rotavirus 1 2.9% 
-Campylobacter jejuni 1 2.9% 
Cerebrospinal fluid 1 2.9% 
-Streptococcus pneumoniae 1 2.9% 
Laboratory findings of patients with CVST 
Hb: haemoglobin; GBS: group B streptococcus; CNSA: coagulase negative 
staphylococcus aureus 
 
Neurological outcome at discharge: 
 
Two patients (5,7%) demised and 13 patients (37.1%) had neurological deficits at 
discharge. These neurological deficits included increased tone globally without 
obvious weakness, decreased tone globally, cortical blindness, spastic quadriplegia, 
cranial nerve palsies and a patient with a persistent vegetative state. Long term 
neurological assessment was not documented.   
 
Eleven of the thirteen patients who had neurological deficits at discharge presented 
with convulsions. Only 4 of these thirteen patients had neurological fallout on 
presentation. Six of the 13 patients had a normal level of consciousness and 7 had a 
depressed level of consciousness at presentation. Of the 25 patients that presented 
with convulsions, 13 (52%) had no neurological deficits at discharge and 11 (44%) 
had neurological deficits at discharge. Seizures were not a statistically significant 
predictor of poor neurological outcome. (p=0.25) 
 
Of the 8 patients who presented with a depressed level of consciousness, 7 (87.5%) 
had neurological deficits at discharge. Six of the 27 patients (22.2%) who presented 
with a normal level of consciousness had neurological deficits at discharge. Of the 2 
patients who demised, both presented with a normal level of consciousness and had 
no neurological fallout on presentation. One of the two patients had generalized 
convulsions on presentation. A poor neurological outcome was not associated with 
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convulsions (p=0.25) or a decreased level of consciousness at presentation (p=0.89). 
Age of <6 months and the involvement of the deep venous system was also not 
associated with poor neurological outcome (p>0.5).  





This is a case series of 35 children who developed a cerebral venous sinus thrombosis 
(CVST) as proven by contrasted brain CT imaging in a tertiary care hospital in a 
resource-constrained country. The development of CVST was strongly associated 
with hypernatraemic dehydration following acute gastroenteritis, an association not 
well-documented in the literature. Neurological deficit (37.1%) at discharge was 
common although the mortality was only 5.7%.  
 
The mean age of the patients in our study was 16.9 months. This is younger than 
reported in previous studies where the mean age varied between 4 and 5.6 years.(4,9) 
This difference might be due to the burden of infectious disease and particularly of 
gastro-enteritis in children younger than 2 years in the Western Cape Province of 
South Africa. In our study, the patients less than a year old made up 80% of the case 
series. This trend is also seen in the Canadian series and a large series from the 
USA.(1,7) 
 
Our study further differs in that we have much fewer neonates (13.9%) than reported 
in previous studies (19%-69%).(1,2,4,7,11) The difference might be explained by a 
sampling bias as only neonates admitted to the general paediatric wards were 
included. We report a higher proportion of male children (57%) who develop CVST 
but this is concordant to other studies.(2,4–6,9,24) 
 
The mean weight on admission (mean weight for age Z-score = -2) of our study 
patients reflects that our patients are severely underweight for age according to the 
WHO classification. This might be an over-estimate of the degree of malnutrition as 
more than half of the children included in this series presented with acute gastro-
enteritis (AGE). These children’s weight could have been underestimated due to 
dehydration. Two patients had documented kwashiorkor. No previous study on CVST 
has reported on the association of malnutrition, acute gastroenteritis and CVST. The 
pathogenesis of CVST might differ in this vulnerable group of patients.  
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Acute gastro-enteritis was the single most important acute associated illness found in 
our study (68.6%). This indicates the high prevalence of AGE in our setting. What 
could also be a contributing factor is that the Rotavirus vaccine was introduced in 
South Africa only in 2009 and the national roll-out thereof was only introduced in 
April 2010.(25) Patients in this study would have only benefitted from the 2 doses 
towards the end of 2010.  
 
In stark contrast to this study where AGE was the commonest precipitating factor in 
the development of CVST, other studies have not found this strong association.  
Heller et al. mentioned gastroenteritis as an acute associated illness (4/149) (2.6%)(2) 
and Sebire et al. found 12% of the patients in his series had acute diarrhoea.(5) These 
studies reported on high-income countries where AGE causing severe dehydration is 
less common which could explain the differences between the studies. All the other 
studies mention dehydration as an associated condition and potential risk factor but 
the cause of the dehydration is not stated. The incidence of dehydration in these 
studies is between 0.05% - 21%.(5–7)  
 
The second most common acute associated condition in our study was meningitis 
(25,7%), which is classified as a local infection. In previous studies meningitis had an. 
incidence of between 3%-13(2,4,6,7) Only Barnes et al.(9) found a higher incidence 
(44%), but their figure included cases of brain abscesses. Our findings of meningitis 
are much higher than previous studies. This might again be due to the great burden of 
poor social circumstances and high incidence of infectious diseases we see in our 
resource-constrained setting. 
 
Mastoiditis has an incidence of between 23%-47%.(4–7,9,11) Only Heller et al. had a 
lower incidence of 9%.(2) In our study only 1 patient was found to have mastoiditis. 
This might be due to referral bias. Paediatric patients who need specialist ENT 
services gets referred directly to the ENT department and are not admitted to the 
paediatric wards. As mentioned before only Barnes et al found brain abscesses as an 
acute associated finding. In our study 4 patients (11.4%) had brain abscesses. Two 
abscesses were associated with presumed bacterial meningitis, 1 abscess was 
associated with disseminated tuberculosis and 1 abscess was associated with a post-
operative complication for oesophageal dilatation after caustic ingestion. This again 
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reflects the burden of infectious diseases such as meningitis and tuberculosis in the 
population this hospital serves. 
 
Our study found that chronic underlying conditions were not a significant risk factor 
for the development of CVST. In our study, 14.3% of the CVST cases were HIV-
infected. This is the first report on the association of HIV-infection with CVST but 
this association is probably complex as all 5 of the HIV-infected children also 
suffered from AGE. Due to the study design this multivariate association could not be 
explored.   
 
It is widely reported in the literature that children that develop CVST have underlying 
predisposing diseases.  In our study only 5.7% (n=2) of the patients did not have an 
associated disease. Although our figure agrees with the 3% reported by DeVeber it 
differs significantly from the normally reported 10-30%.(2,6,7,11) This finding is not 
easy to explain but considering that AGE was the commonest associated disease with 
CVST it might indicate that delayed access to health care and/or severe dehydrating 
AGE are important factors in the development of CVST. Similarly, it has been 
reported that multiple predisposing factors are present in children who develop 
CVST.(7) In our study we report that 54.3% of those who developed CVST had 2 or 
more predisposing factors. We demonstrate in our cohort, that malnutrition, AGE and 
multiple predisposing factors uniquely elevate the risk of developing CVST in a 
resource-constrained setting. None of our patients had prothrombotic screens done. It 
is unsure whether patients in our population would benefit from this screen seeing that 
only 2 patients had no underlying cause found. This is a rather expensive screen and 
prospective studies with prothrombotic screens are recommended in our setting to 
validate these high costs. 
 
Level of consciousness, seizures and abnormal neurological signs are consistently 
described as clinical features associated with CVST. Twenty-five patients (71.4%) in 
our study had seizures at presentation. This number is higher than expected when 
compared to previous studies. Previous studies reported associated seizures between 
25%-58%.(1–4,9,22,24) This discordancy might be due to the high number of patients 
with hypernatraemia (48.6%) in our study. Hypernatraemia alone predisposes patients 
to seizures and the rapid correction thereof further predisposes the patient to seizures. 
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The high number of patients with meningitis and brain abscesses can further be a 
cause for the high number of patients who presented with seizures. Level of 
consciousness and neurological fallout in our study matched the previous studies.  
 
Hypernatraemia was a significant abnormal laboratory finding in our study. High 
serum osmolality has not been described in the literature as a risk factor for CVST. In 
our study 17 patients (48.6%) had a serum sodium level of >145mmol/l which was 
associated with AGE in all the cases. Dehydration has previously been described as 
causative of CSVT in resource-constrained countries, but the cause thereof and 
osmolality was not reported. CVST secondary to hypernatraemic dehydration caused 
by diarrhoeal diseases is widely accepted by clinicians through clinical experience in 
South Africa. In a review article by Roach et al. he stated that hypernatraemia in 
conjunction with dehydration may cause CVST.(17) He based this on two studies 
published in the 1950’s and 1960’s by Finberg and Macauly, however it has been 
reported infrequently in the literature. Vieira et al. reported a single patient with 
hypernatraemic dehydration in his study.(6) 
 
Anaemia has been described in the literature as a possible risk factor for CVST. In our 
study 25 patients (71.4%) was classified as being anaemic for age. This is higher than 
the 10% reported by Wasay et al, and 52% reported by Sebire et al. This might be due 
to the poor food security and lack of quality animal protein in our population’s diet. 
We have failed to show a low MCV count in our patients as previously described as a 
risk factor for stroke.(14) 
  
Our study is the first study to document organisms isolated from the study patients. 
This is significant because it reinforces the burden of infectious diseases in a 
resource-constrained country like South Africa. Of the 35 patients in our study, 31.4% 
had organisms identified in various sample types. 
 
The superior sagittal, transverse and straight sinuses were more frequently involved in 
our patient population, which is similar to other studies in the literature.(5,14,18,26) 
We report that multiple sinus thrombosis was common and occurred in almost two-
thirds of our patients, which was similar to the reported literature (11%-70%). The 
superficial venous system alone was affected more often (97.1%), correlating with the 
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literature.(1,22,24) A unique statistically-significant finding in our study was 
thrombosis of the deep venous sinus system associated with hypernatraemia following 
AGE. Hydrocephalus as an associated involvement occurred in 8.6% of our patients, 
which has not previously been described.  Only 4 patients (11.4%) had associated 
haemorrhage, which is lower than mentioned in the literature. Morbidity, as well as 
mortality in our study correlates with the literature.(2,5,6,11)  
 
The major limitation of this study is the retrospective nature. There is possible 
sampling bias, as not all the patients suffering from CVST were included, especially 
neonates. Only neonates admitted to the paediatric wards were included. The sample 
size of the study is relatively small, limiting the ability of the study to determine 
associations that may differ when comparing resource-constrained to adequately 
resourced countries.  
Another limitation of this study is that the diagnosis of CVST would more likely 
occur in children with specific signs and symptoms such as focal convulsions, 
depressed LOC and neurological deficit. Asymptomatic cases would remain 
unidentified. 
Although this study has considerable internal validity the external validity and 




CVST is a relatively uncommon disorder in neonates and children, which is often not 
clinically suspected but has the potential to result in severe neurological disability 
especially in children living in resource-constrained settings. Our study is the first of 
its kind in South Africa and for that matter in any other resource-constrained country. 
In this study we demonstrated that hypernatraemia and AGE appear to be a significant 
acute underlying risk factor for developing CVST. Further, we found that CVST is 
more common in younger children, in those with severe underweight-for-age and 
when associated with AGE, than has previously been reported in studies from 
adequately resourced countries. Further studies in resource-constrained countries are 
required to confirm these important associations to develop interventions to prevent 
CVST occurring in these vulnerable children.   





Prospective studies in the South African context should be conducted on paediatric 
CVST. These studies should include response to treatment and serum thrombotic 
workup as part of the protocol as the role of inherited or acquired underlying 
thrombotic predisposition in our population is not known. 
 
Awareness of the occurrence of CVST in the Southern African context needs to be 
increased to ensure that complications are not underdiagnosed and mismanaged. 
For improved outcome, better vigilance of CVST should be exercised in children who 
present with hypernatraemic dehydration with seizures and/or neurological deficits, so 
that neuroimaging can be timeously obtained to guide the initiation of anticoagulation 
therapy. 
 
As the clinical features of CVST can be subtle, patients with hypernatraemia should 
be closely followed up after discharge and assessed for neuro-developmental, 
neurological or cognitive deficits to ensure appropriate treatment. 
 
A prospective study should be carried out in a neonatal population to determine the 
risk factors for the development of CVST and determine the extent of neurological 
damage in this group. 
 
As AGE is the commonest cause of CVST in a resource-constrained country a study 
to investigate the impact of rotavirus immunization on the prevalence of CVST 
should be carried out. 
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A Retrospective Review of Paediatric Cerebral Venous Sinus Thrombosis in a 




Paediatric cerebral venous sinus thrombosis (CVST) is a rare disorder with an 
estimated incidence of 0.67 per 100,000 children in developed countries.(1) It is a 
devastating disease with potentially severe neurological sequelae and a high mortality 
rate, highlighting the need for high-quality studies within this field. No data on 
paediatric CVST are known for South Africa or even the continent of Africa. Most 




As many as 43% of CVST cases occur in the first month of life(1),  with an incidence 
of 2.6 per 100,000 children per year in one series in the neonatal period(2). CVST 
after the neonatal period has an almost equal sex ratio with a slight increase in males 




Cerebral venous sinus thrombosis is thrombosis of intracranial venous sinuses and/or 
cerebral veins. Thrombosis within the venous system results in outflow obstruction, 
venous congestion, and a consequent increase in capillary hydrostatic pressure, 
driving fluid into the interstitium and producing oedema. This also leads to impaired 
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Aetiology 
The origin and pathophysiology of CVST is poorly understood. Published data 
suggest that CVST is multifactorial in origin with many associated underlying 
illnesses or chronic conditions.(1,2,4,6,7,9–11,22) 
Associated underlying illnesses include common childhood systemic illnesses such as 
infections, dehydration, fever and anaemia.  Associated chronic conditions include 
malignancies, nephrotic syndrome, systemic lupus erythematosis and congenital 
cardiac diseases.  
 
Infection appears to be a significant trigger in previously well children without 
underlying medical conditions. Infections associated with CVST can either be 
systemic, such as bacterial sepsis, or regional, such as meningitis, mastoiditis and 
otitis media. Other local head and neck disorders can cause thrombosis due to local 
venous stasis. These include recent head/neck surgery, head trauma and CNS 
tumours.  
 
CVST has been described as a complication of L-asparaginase use in the treatment of 
acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma. L-asparaginase is 
thought to create a pro-thrombotic state, alone or in combination with other 
chemotherapeutic agents.(4,6,12,13) 
Anaemia is frequently observed in children with CSVT(7,22), though mechanisms for 
its contribution to thrombus development are incompletely understood. Iron 
deficiency microcytic anaemia are most commonly described in CVST. It is found 
that previously healthy children with stroke were 10 times more likely to have iron 
deficiency anaemia than healthy children without stroke.(14) 
 
Prothrombotic states may cause or contribute to CVST in children. The association 
between prothrombotic risk factors and CVST proves only to be statistically 
significant if the thrombosis is in combination with an underlying condition. (2,11) 
 
CVST has been described as a complication (underlying/associated illness) of 
dehydration in children. Although CVST secondary to hypernatraemic dehydration in 
breastfed neonates has been described in the literature(15,16), there is limited clinical 
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data on CSVT secondary to hypernatraemic dehydration due to diarrhoeal disease in 
infants and young children. However,   (Personal communication: Nel ED, Solomons 
R), CSVT is however widely accepted as a complication of hypernatraemic 





The clinical manifestations of CVST can be subtle and are nonspecific. Due to its 
rarity and the nonspecific clinical features at presentation the diagnosis of CVST is 
often delayed and may be missed altogether. One study reported an average delay in 
diagnosis of CVST of up to 4 days.(6) Most common clinical features at presentation 
are seizures, fever, drowsiness/stupor, headaches and generalized weakness. Common 
neurological abnormalities at presentation are decreased level of consciousness, 
cranial nerve palsies and hemiparesis. While most of the clinical symptoms can occur 
at any age, seizures are more common in neonates, and focal and diffuse neurologic 
signs are more common in older infants and children.(1,2,5–7,9,10) 
 
 
Topographic location of thrombi 
The superficial venous system (dural venous sinuses) is more frequently involved 
than the deep system (composed of traditional veins inside the deep structures of the 
brain, which join behind the midbrain to form the vein of Galen), and the most 
common sites of CSVT are the transverse, superior sagittal, sigmoid, and straight 
sinuses.(6) 
These topographic locations differ however with presence of underlying intracranial 
pathology. In one study the transverse sinus was mostly affected secondary to the 




The treatment of CVST in children is not well described. The primary treatment is to 
treat the underlying cause or associated clinical condition and general supportive care. 
Anticoagulation therapy has been used in children with CVST. Case series reports 
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have shown that LMWH (low molecular weight heparin) can be used safely in 
children, however data is limited to support the efficacy of this treatment. (22) In a 
study on treatment practices in neonatal CSVT it was found that antithrombotic 
treatment practices demonstrate considerable variability and uncertainty about the 
indications for antithrombotic therapy. This highlights the importance of further 
studies around treatment options of paediatric CVST. (27)  
 
Prognosis and outcome 
CVST has a variable prognosis with three major studies in Europe(5), North 
America(1) and Australia(9) estimating its morbidity between 38% - 60% and 
mortality between 10% -12%. In an American study they found that permanent 
neurological disability was associated with thrombosis of the deep veins with 
associated infarctions.(3) Coma is the only predictor of death in childhood CVST.(5) 
One study reports that older age and involvement of the lateral and/or sigmoid sinuses 
are associated with good cognitive outcome.(5) Common long-term sequelae include 
motor impairment, cognitive impairment, developmental and/or speech delay, and 
visual impairment. (1,5,21) 
 
Recurrence of CSVT is uncommon. The Canadian study by DeVeber et al in 160 
children with CSVT identified 12 children with recurrent thrombosis.(1) 
The study by Kenet et al. in 266 children with CSVT found that venous thrombosis 




Previous studies that have been done on cerebral venous sinus thrombosis were done 
in developed countries of Europe, North America and Australasia. No study on CVST 
has been done in developing Sub-Saharan Africa, or more specifically, South Africa. 
The aetiological differences of CSVT between developed and developing countries 
such as South Africa are not known. It is expected that the aetiology will lean more 
towards complications of infections such as diarrhoea and meningitis because of the 
high incidence of these diseases in South Africa. 
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Dehydration is mentioned as a cause of CSVT in developed countries but the cause of 
dehydration and osmolality is not mentioned or known.  
CSVT secondary to hypernatraemic dehydration caused by diarrhoeal diseases is 
widely accepted by clinicians through clinical experience, however this is not proven.   
 
Treatment of Paediatric CVST is still very controversial.  There are currently no well-
designed clinical trials in children to support acute or chronic antithrombotic therapy 
with anticoagulants or antiplatelet agents once the diagnosis of CSVT is made. 
Randomized control trials in the paediatric population are needed in order for 
treatment consensus to be reached. 
 
The aim of this study is to evaluate and study the confirmed cases of CVST in a South 
African population to see the differences in this disease between developed and 
developing countries. This will serve as an important pilot study for cerebral venous 
sinus thrombosis as it will be the first of its kind in South Africa. By studying this 
disease in a South African setting we can come to a better understanding of the risk 
factors and associated factors of CSVT. It will be of great benefit in early recognition 






To describe the patients diagnosed with CVST who presented to Tygerberg 
Children’s Hospital with regards to patient profile, clinical presentation, aetiology and 






To describe patients who presented to Tygerberg Children’s Hospital diagnosed with 
CVST with regards to the following parameters: 
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1. Age at presentation and sex. 
 
2. To describe the signs and symptoms on admission and to describe any neurologic 
deficit noted at presentation. 
 
3. Any associated acute medical illnesses or underlying chronic medical conditions. 
 
4. To document any electrolyte abnormality at presentation. (refer to data capture 
sheet) 
 
5. To document haematological abnormalities at presentation. ( Haemoglobin, 
Platelet level) 
 
6. To assess anthropometry of the patients at presentation. 
 
7. To assess time delay (in days) from presentation to diagnosis.  
 
8. Document the thrombotic location on CT scan or MRI scan. 
 











Children between the ages of 1 day to 12 years admitted to Tygerberg Children’s 
Hospital from January 2009 to February 2014 who were diagnosed with cerebral 
venous sinus thrombosis. 
 




 Admission dates: 1 January 2009 to 28 February 2014 
 Ages: 1 day to 12 completed years 





 Radiological images not available. 











Patients eligible for this study will be identified from electronic discharge summaries 




Database and data collection 
 
 Patient clinical data will be collected retrospectively from their patient files: 
either from the hard copy patient files or from the electronic patient files on 
the Enterprise Content Management (ECM) system. The ECM system might 
not contain all patient files due to its recent inception in Tygerberg Hospital. 
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 Patient radiological data, MRI and CT Scan data, will be collected from 
Tygerberg’s iSite enterprise.  
 Patient blood results will be collected from the National Health Laboratory 
Service application. 
 After data capturing is completed, the data will be categorized, processed and 
analyzed in order for the dissertation to be written. 
 All data will be stored in Microsoft Excel on a password protected computer. 




The patient data will be captured on a research data form, which will not contain any 
identifiable personal information, only the study number of the patient. (See 
addendum A). The following information will be captured: 
 
 
 Demographic information:   
o Age and weight on admission.  
o Gender 
 
 Associated underlying illnesses:  
o These are conditions diagnosed alongside the CVST on the same 
admission. 
o If an infective illness is identified: Micro-organism isolated/cultured 
 
 Chronic illnesses:  
o These are underlying chronic medical conditions that the patient is 
known with. 
 
 Signs and symtoms at presentation:  
o These are signs and symptoms that the child presented with in the 
emergency centre  
o If dehydration was present – percentage of dehydration  
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 Neurological signs at presentation:  
o Neurological fallout present at presentation to the emergency centre. 
1. Loss of consciousness (Glasgow-coma scale) 
2. Focal motor deficit 
 
 Seizures:   
 Seizures present around time of diagnosis of CVST during admission  
o Character of seizure – generalized or focal in nature   
o Duration of seizure 
o Seizure response to anticonvulsant 
 
 Time delay of diagnosis (Time from admission to imaging)  
 
 Elecrolyte abnormalities: 
o Serum sodium on admission (within 24 hours) 
o Serum urea and creatinine on admission (within 24 hours) 
o If there was a derangement in the above – time (in hours) to correction 
 
 Haemoglobin, platelet and mean corpuscular volume level at diagnosis: 
o To establish whether haematological abnormalities were present at 
presentation. 
 
 Neurological deficit on discharge from Tygerberg children’s Hospital 
 
 Neuro Imaging: 
o Radiological data, MRI and CT Scan data, will be collected from 
Tygerberg’s iSite enterprise. 
o Radiological images will be reviewed by Dr R Solomons, Specialist 
Paediatric Neurologist and sub-investigator of this study, to confirm 
the diagnosis of CSVT and will be independently reviewed by a 
paediatric radiologist. Disagreements in interpretation will be resolved 
by consensus and reported as such. 
Stellenbosch University  https://scholar.sun.ac.za
 49 
o Radiological data that will be captured are: 
1. Imaging technique used 
2. Location of thrombosis 
3. Size of thrombosis 
4. Presence of associated venous infarct or bleed 









Statistica® version 12 (Statsoft) will be used to analyse the data. 
Descriptive Statistics 
 
Variables recorded the study will be summarized using standard descriptive 
statistical methods: 
1. Continuous variables that follow a normal distribution will be 
described by a mean and standard deviation. 
2. Continuous variables that do not follow a normal distribution will be 
described by the median and inter-quartile range. 
3. Proportions will be described by the proportion estimate and the 95% 
confidence interval. 
Inferential Statistics 
1. Differences between groups (e.g. presence or absence of neurological 
complications, venous infarct, associated diseases) will be analysed by 
analysis of variance or the non-parametric equivalent (where data can 
be categorised). 
2. Associations between variables will be analysed by regression (linear, 
logistical, simple or multiple) analysis (e.g. association between 
highest serum sodium concentration and presence of neurological 
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outcome, association between size or location of the infarct and 
neurological outcome, association between age and infarct size, 
neurological outcome) 












Patient demographic data will be kept strictly confidential at all times by only using 
study numbers in the data management and analysis stages of this study. 
The information for this study will be collected in such a way as to protect patient 
confidentiality at all times. The data capture sheet and electronic database will only 
contain a study code. The identifying information that is linked to the study code will 
be kept in a separate, password protected database. Access to this database will be 
restricted to the primary investigator. 
All data will be kept for a maximum of 5 years in a safe, password restricted database 





We request a waiver of individual informed consent as this is a retrospective study 
with minimal risks to the study participants. 
We have requested permission to conduct this retrospective study from the Medical 
Superintendent of Tygerberg Hospital as the custodian of the data. 
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Benefit to the Individual Participant 
 
This study will not have any benefit to the specific participants due to the 
retrospective nature thereof. 
However if it is found that a participant with significant complications has been lost 
to follow up or has not received optimal treatment (e.g. occupational therapy for 





Benefit to the community 
 
There are many unanswered questions surrounding CVST in the paediatric population 
in not only the world, but in South Africa. The aetiology and prognosis of paediatric 
CSVT in South Africa are not known. This study will be the first study in South 
Africa to assess paediatric CVST and will serve as the basis for further studies to 
identify the risk factors associated with and prevention of CVST in order for early 





The protocol for the proposed study will be submitted for approval to the Committee 
of Human Research of the Faculty of Health Sciences, University of Stellenbosch. 






 The total cost of the study, which is projected to be at a minimum, will be 
covered by the investigators. 
 




Item Amount Cost per unit Total 
Pages and printing 1000 32c R320 










STRENGTHS AND LIMITATIONS 
 
 Because of the retrospective nature of the study and the unknown incidence of 
the proposed study topic in the South African population it is uncertain how 
big the study population will be. Due to the lack of a formal stroke registry 
and rarity of the condition it is expected that the study population will be 
small.  
 It is unsure how much of the data intended for collection have been recorded 
in the clinical notes and therefore how much will be available for capturing. 
 The greatest strength of this study is that this topic have not been reviewed in 
South Africa or Sub-Saharan Africa. This study can serve as a pilot study for 
future prospective studies. 
 
REPORTING OF RESULTS 
 
This study will be published in a peer review journal and presented at National 
conferences 
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Time from admission to diagnosis(days): 
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